Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation
N Doherty, S L Hancock, S Kaye, et al.
Gene Therapy
|
June 14, 2000
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling, G Cruickshank, V Papanastassiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks
S Senan, R Rampling, M A Graham, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial
M A Graham, S Senan, H Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1987
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies
A A Epenetos, A J Munro, S Stewart, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 7, 2003
Don't wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression
P Levack, J Graham, D Collie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
C Twelves, M Campone, B Coudert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia, Roger Stupp, Alba A Brandes, et al.
British Journal of Cancer
|
January 19, 2000
Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model
R J Mairs, C L Wideman, W J Angerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation
N Doherty, S L Hancock, S Kaye, et al.
Gene Therapy
|
June 14, 2000
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling, G Cruickshank, V Papanastassiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 1997
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks
S Senan, R Rampling, M A Graham, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Pharmacokinetics of the hypoxic cell cytotoxic agent tirapazamine and its major bioreductive metabolites in mice and humans: retrospective analysis of a pharmacokinetically guided dose-escalation strategy in a phase I trial
M A Graham, S Senan, H Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1987
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies
A A Epenetos, A J Munro, S Stewart, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
January 7, 2003
Don't wait for a sensory level--listen to the symptoms: a prospective audit of the delays in diagnosis of malignant cord compression
P Levack, J Graham, D Collie, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Phase II study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme
C Twelves, M Campone, B Coudert, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2012
New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials
Thierry Gorlia, Roger Stupp, Alba A Brandes, et al.
British Journal of Cancer
|
January 19, 2000
Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model
R J Mairs, C L Wideman, W J Angerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, et al.
Page
of 6